Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

PRV-3279-2a Trial in Systemic Lupus

ClinicalTrials.gov ID: NCT05087628

Public ClinicalTrials.gov record NCT05087628. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 24, 2026, 4:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2a, Randomized, Double-blind, Placebo-controlled Trial of PRV-3279 EVAluation In Lupus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The PREVAIL-2 study was designed to assess the safety and potential efficacy of PRV-3279 in flare prevention in systemic lupus erythematosus (SLE) participants with active disease after amelioration induced by corticosteroid treatment.

Study identification

NCT ID
NCT05087628
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Enrollment
28 participants

Conditions and interventions

Interventions

Biological · Other

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 19, 2022
Primary completion
May 13, 2024
Completion
Jun 23, 2024
Last update posted
Apr 2, 2026

2022 – 2024

United States locations

U.S. sites
22
U.S. states
8
U.S. cities
20
Facility City State ZIP Site status
Medvin Clinical Research - Apple Valley- Site Number : 133 Apple Valley California 92307 —
Medvin Clinical Research - Covina - West San Bernardino Road- Site Number : 106 Covina California 91722 —
University of California San Diego - La Jolla- Site Number : 108 La Jolla California 92037 —
University of California Los Angeles Medical Center- Site Number : 122 Los Angeles California 90095 —
Facey Medical Group - Los Angeles- Site Number : 126 Los Angeles California 91345 —
Desert Medical Advances- Site Number : 114 Rancho Mirage California 92270 —
Medvin Clinical Research - Tujunga- Site Number : 119 Tujunga California 91042 —
Medvin Clinical Research - Whittier- Site Number : 118 Whittier California 90602 —
Highlands Advanced Rheumatology & Arthritis Center- Site Number : 116 Avon Park Florida 33825 —
Center for Rheumatology, Immunology and Arthritis- Site Number : 109 Fort Lauderdale Florida 33309 —
Millennium Research- Site Number : 111 Ormond Beach Florida 32174 —
D&H Tamarac Research Center- Site Number : 123 Tamarac Florida 33321 —
Florida Hospital Tampa- Site Number : 107 Tampa Florida 33613 —
Vernon Hills Medical Associates- Site Number : 128 Vernon Hills Illinois 60061 —
Ochsner Medical Center - Jefferson Highway- Site Number : 113 New Orleans Louisiana 70121 —
Revival Research Corporation - Michigan - ClinEdge - PPDS- Site Number : 124 Troy Michigan 48084 —
University of Toledo Medical Center- Site Number : 110 Toledo Ohio 43614 —
Yale University School of Medicine- Site Number : 125 Pittsburgh Pennsylvania 15213-2536 —
Grapevine Rheumatology Clinic- Site Number : 103 Grapevine Texas 76051 —
Accurate Clinical Management - Greenhouse Road- Site Number : 104 Houston Texas 77084 —
Accurate Clinical Research - Houston Resource Parkway- Site Number : 105 Houston Texas 77089 —
Sun Research Institute- Site Number : 121 San Antonio Texas 78215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05087628, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 2, 2026 · Synced Sep 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05087628 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →